1
|
Mazhar S, Simon A, Khokhlova E, Colom J, Leeuwendaal N, Deaton J, Rea K. In vitro safety and functional characterization of the novel Bacillus coagulans strain CGI314. Front Microbiol 2024; 14:1302480. [PMID: 38274758 PMCID: PMC10809412 DOI: 10.3389/fmicb.2023.1302480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 12/22/2023] [Indexed: 01/27/2024] Open
Abstract
Introduction Bacillus coagulans species have garnered much interest in health-related functional food research owing to their desirable probiotic properties, including pathogen exclusion, antioxidant, antimicrobial, immunomodulatory and food fermentation capabilities coupled with their tolerance of extreme environments (pH, temperature, gastric and bile acid resistance) and stability due to their endosporulation ability. Methods In this study, the novel strain Bacillus coagulans CGI314 was assessed for safety, and functional probiotic attributes including resistance to heat, gastric acid and bile salts, the ability to adhere to intestinal cells, aggregation properties, the ability to suppress the growth of human pathogens, enzymatic profile, antioxidant capacity using biochemical and cell-based methods, cholesterol assimilation, anti-inflammatory activity, and attenuation of hydrogen peroxide (H2O2)-induced disruption of the intestinal-epithelial barrier. Results B. coagulans CGI314 spores display resistance to high temperatures (40°C, 70°C, and 90°C), and gastric and bile acids [pH 3.0 and bile salt (0.3%)], demonstrating its ability to survive and remain viable under gastrointestinal conditions. Spores and the vegetative form of this strain were able to adhere to a mucous-producing intestinal cell line, demonstrated moderate auto-aggregation properties, and could co-aggregate with potentially pathogenic bacteria. Vegetative cells attenuated LPS-induced pro-inflammatory cytokine gene expression in HT-29 intestinal cell lines and demonstrated broad antagonistic activity toward numerous urinary tract, intestinal, oral, and skin pathogens. Metabolomic profiling demonstrated its ability to synthesize several amino acids, vitamins and short-chain fatty acids from the breakdown of complex molecules or by de novo synthesis. Additionally, B. coagulans CGI314's strong antioxidant capacity was demonstrated using enzyme-based methods and was further supported by its cytoprotective and antioxidant effects in HepG2 and HT-29 cell lines. Furthermore, B. coagulans CGI314 significantly increased the expression of tight junction proteins and partially ameliorated the detrimental effects of H2O2 induced intestinal-epithelial barrier integrity. Discussion Taken together these beneficial functional properties provide strong evidence for B. coagulans CGI314 as a promising potential probiotic candidate in food products.
Collapse
Affiliation(s)
- Shahneela Mazhar
- ADM Cork H&W Limited, Bio-Innovation Unit, University College Cork, Cork, Ireland
| | - Annie Simon
- ADM Cork H&W Limited, Bio-Innovation Unit, University College Cork, Cork, Ireland
| | - Ekaterina Khokhlova
- ADM Cork H&W Limited, Bio-Innovation Unit, University College Cork, Cork, Ireland
| | - Joan Colom
- ADM Cork H&W Limited, Bio-Innovation Unit, University College Cork, Cork, Ireland
| | - Natasha Leeuwendaal
- ADM Cork H&W Limited, Bio-Innovation Unit, University College Cork, Cork, Ireland
| | - John Deaton
- ADM Deerland Probiotics and Enzymes, Kennesaw, GA, United States
| | - Kieran Rea
- ADM Cork H&W Limited, Bio-Innovation Unit, University College Cork, Cork, Ireland
| |
Collapse
|
2
|
Simon A, Mazhar S, Khokhlova E, Leeuwendaal N, Phipps C, Deaton J, Rea K, Colom J. Solarplast ®-An Enzymatically Treated Spinach Extract. Plants (Basel) 2023; 12:2678. [PMID: 37514292 PMCID: PMC10384499 DOI: 10.3390/plants12142678] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Revised: 06/30/2023] [Accepted: 07/14/2023] [Indexed: 07/30/2023]
Abstract
In the modern world we are constantly bombarded by environmental and natural stimuli that can result in oxidative stress. Antioxidant molecules and enzymes help the human body scavenge reactive oxygen species and prevent oxidative damage. Most organisms possess intrinsic antioxidant activity, but also benefit from the consumption of antioxidants from their diet. Leafy green vegetables such as spinach are a well-researched rich source of dietary antioxidant molecules. However, plant cell walls are difficult to digest for many individuals and the bio-accessibility of nutrients and antioxidants from these sources can be limited by the degree of digestion and assimilation. Through a specific enzymatic process, Solarplast® contains organic spinach protoplasts without the cell wall, which may facilitate higher yield and efficacy of beneficial antioxidant molecules. In this study, analytical techniques coupled to in vitro bioassays were used to determine the potential antioxidant activity of Solarplast® and determine its antioxidant enzymatic capabilities. Solarplast® demonstrated superior antioxidant activity when compared to frozen spinach leaves in TOC, FRAP and TEAC antioxidant assays. Several antioxidant enzymes were also increased in Solarplast®, when compared to frozen spinach. As a functional readout, Solarplast® attenuated hydrogen peroxide-, ethanol- and acetaminophen-induced increases in oxidative stress and cytotoxicity in both intestinal (HT-29) and liver (HepG2) cell lines. These findings suggest that Solarplast® may represent a non-GMO, plant-based food supplement to help reduce oxidative stress in the human body.
Collapse
Affiliation(s)
- Annie Simon
- ADM Cork H&W Limited, Food Science Building, University College Cork, T12 Y337 Cork, Ireland
| | - Shahneela Mazhar
- ADM Cork H&W Limited, Food Science Building, University College Cork, T12 Y337 Cork, Ireland
| | - Ekaterina Khokhlova
- ADM Cork H&W Limited, Food Science Building, University College Cork, T12 Y337 Cork, Ireland
| | - Natasha Leeuwendaal
- ADM Cork H&W Limited, Food Science Building, University College Cork, T12 Y337 Cork, Ireland
| | - Christopher Phipps
- ADM Deerland Probiotics and Enzymes, 3800 Cobb International Boulevard, Kennesaw, GA 30152, USA
| | - John Deaton
- ADM Deerland Probiotics and Enzymes, 3800 Cobb International Boulevard, Kennesaw, GA 30152, USA
| | - Kieran Rea
- ADM Cork H&W Limited, Food Science Building, University College Cork, T12 Y337 Cork, Ireland
| | - Joan Colom
- ADM Cork H&W Limited, Food Science Building, University College Cork, T12 Y337 Cork, Ireland
| |
Collapse
|
3
|
Rea K, Colom J, Simon EA, Khokhlova E, Mazhar S, Barrena M, Enrique M, Martorell P, Perez BA, Tortajada M, Phipps C, Deaton J. Evaluation of Bacillus clausii CSI08, Bacillus megaterium MIT411 and a Bacillus cocktail on gastrointestinal health: a randomised, double-blind, placebo-controlled pilot study. Benef Microbes 2023; 14:165-182. [PMID: 37026366 DOI: 10.3920/bm2022.0117] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/08/2023]
Abstract
In the present study, the safety, tolerance and impact of 1×109 cfu Bacillus clausii CSI08, 1×109 cfu Bacillus megaterium MIT411 and a probiotic cocktail containing Bacillus subtilis DE111®, Bacillus megaterium MIT411, Bacillus coagulans CGI314, and Bacillus clausii CSI08 with a total count of 2.0×109 cfu administered daily were assessed as compared with a maltodextrin containing placebo control. A total of 98 study participants received daily doses for 45 days, followed by a washout period of 2 weeks. A questionnaire to capture the incidence and duration of upper respiratory tract, urinary tract and/or gastrointestinal complaints and a diary to capture stool regularity and consistency was kept daily to record compliance throughout the 45 days. Faecal and blood samples were collected for microbiological and haematological analysis at the start and end of the treatment period. The probiotic cocktail significantly decreased the incidence of loose stools throughout the entire study. The recorded respiratory, urinary and gastrointestinal symptoms, defecation frequency and other stool consistency were not influenced. No clinically relevant changes in blood parameters, such as liver and kidney function and no serious adverse events appeared during and after administration. There were no changes in symptoms including sadness, irritability, energy, appetite, tension, stress, sleep, cardiovascular events, aches and pains, and dizziness as determined by a mood questionnaire administered to participants at baseline and at the end of the treatment period. Similarly, the measured inflammatory cytokines, antioxidant levels, cholesterol, triglycerides, free amino acids or minerals remained unaffected. There were no negative changes in alpha or beta diversity of the microbiota with any of the treatment groups. These promising data suggest that these treatments were safe and well tolerated, and further work with larger cohorts are justified to determine the efficacy of these potential probiotics in select demographic groups. Trial registration number with clinicaltrials.gov at NCT04758845.
Collapse
Affiliation(s)
- K Rea
- Deerland Ireland R&D Ltd./ADM, Food Science Building, University College Cork, Cork T12 YT20, Ireland
| | - J Colom
- Deerland Ireland R&D Ltd./ADM, Food Science Building, University College Cork, Cork T12 YT20, Ireland
| | - E A Simon
- Deerland Ireland R&D Ltd./ADM, Food Science Building, University College Cork, Cork T12 YT20, Ireland
| | - E Khokhlova
- Deerland Ireland R&D Ltd./ADM, Food Science Building, University College Cork, Cork T12 YT20, Ireland
| | - S Mazhar
- Deerland Ireland R&D Ltd./ADM, Food Science Building, University College Cork, Cork T12 YT20, Ireland
| | - M Barrena
- ADM Biopolis, Parc Cientific Universitat de Valencia, Catadratico Agustin Escardino Benlloch, 9. Edificio 2, 46980 Paterna, Spain
| | - M Enrique
- ADM Biopolis, Parc Cientific Universitat de Valencia, Catadratico Agustin Escardino Benlloch, 9. Edificio 2, 46980 Paterna, Spain
| | - P Martorell
- ADM Biopolis, Parc Cientific Universitat de Valencia, Catadratico Agustin Escardino Benlloch, 9. Edificio 2, 46980 Paterna, Spain
| | - B Alvarez Perez
- ADM Biopolis, Parc Cientific Universitat de Valencia, Catadratico Agustin Escardino Benlloch, 9. Edificio 2, 46980 Paterna, Spain
| | - M Tortajada
- ADM Biopolis, Parc Cientific Universitat de Valencia, Catadratico Agustin Escardino Benlloch, 9. Edificio 2, 46980 Paterna, Spain
| | - C Phipps
- Deerland Probiotics and Enzymes/ADM, 3800 Cobb International Boulevard Kennesaw, GA 30152, USA
| | - J Deaton
- Deerland Probiotics and Enzymes/ADM, 3800 Cobb International Boulevard Kennesaw, GA 30152, USA
| |
Collapse
|
4
|
Colom J, Freitas D, Simon A, Khokhlova E, Mazhar S, Buckley M, Phipps C, Deaton J, Brodkorb A, Rea K. Acute physiological effects following Bacillus subtilis DE111 oral ingestion - a randomised, double blinded, placebo-controlled study. Benef Microbes 2023; 14:31-44. [PMID: 36790091 DOI: 10.3920/bm2022.0081] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
Previous studies using ileostomy samples from study participants demonstrated that the spore-forming probiotic Bacillus subtilis DE111® can germinate in the small intestine as early as 4 hours after ingestion. Metabolomics, proteomics and sequencing technologies, enabled further analysis of these samples for the presence of hypoglycaemic, hypolipidemic, antioxidant, anti-inflammatory and antihypertensive molecules. In the DE111 treatment group, the polyphenols trigonelline and 2,5-dihydroxybenzoic acid, orotic acid, the non-essential amino acid cystine and the lipokine 12,13-diHome were increased. DE111 also reduced acetylcholine levels in the ileostomy samples, and increased the expression of leucocyte recruiting proteins, antimicrobial peptides and intestinal alkaline phosphatases of the brush border in the small intestine. The combination of B. subtilis DE111 and the diet administered during the study increased the expression of the proteins phosphodiesterase ENPP7, ceramidase ASAH2 and the adipokine Zn-alpha-2-glycoprotein that are involved in fatty acid and lipid metabolism. Acute B. subtilis DE111 ingestion had limited detectable effect on the microbiome, with the main change being its increased presence. These findings support previous data suggesting a beneficial role of DE111 in digestion, metabolism, and immune health that appears to begin within hours of consumption.
Collapse
Affiliation(s)
- J Colom
- Deerland Probiotics and Enzymes, Food Science Building, University College Cork, Cork, Ireland
| | - D Freitas
- Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland
| | - A Simon
- Deerland Probiotics and Enzymes, Food Science Building, University College Cork, Cork, Ireland
| | - E Khokhlova
- Deerland Probiotics and Enzymes, Food Science Building, University College Cork, Cork, Ireland
| | - S Mazhar
- Deerland Probiotics and Enzymes, Food Science Building, University College Cork, Cork, Ireland
| | - M Buckley
- Mercy University Hospital, Grenville PI, Cork, Ireland
| | - C Phipps
- Deerland Probiotics and Enzymes, 3800 Cobb International Boulevard Kennesaw, GA, USA 30152, USA
| | - J Deaton
- Deerland Probiotics and Enzymes, 3800 Cobb International Boulevard Kennesaw, GA, USA 30152, USA
| | - A Brodkorb
- Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland
| | - K Rea
- Deerland Probiotics and Enzymes, Food Science Building, University College Cork, Cork, Ireland
| |
Collapse
|
5
|
Khokhlova E, Colom J, Simon A, Mazhar S, García-Lainez G, Llopis S, Gonzalez N, Enrique-López M, Álvarez B, Martorell P, Tortajada M, Deaton J, Rea K. Immunomodulatory and Antioxidant Properties of a Novel Potential Probiotic Bacillus clausii CSI08. Microorganisms 2023; 11:microorganisms11020240. [PMID: 36838205 PMCID: PMC9962608 DOI: 10.3390/microorganisms11020240] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Revised: 01/10/2023] [Accepted: 01/13/2023] [Indexed: 01/19/2023] Open
Abstract
Spore-forming bacteria of the Bacillus genus have demonstrated potential as probiotics for human use. Bacillus clausii have been recognized as efficacious and safe agents for preventing and treating diarrhea in children and adults, with pronounced immunomodulatory properties during several in vitro and clinical studies. Herein, we characterize the novel strain of B. clausii CSI08 (Munispore®) for probiotic attributes including resistance to gastric acid and bile salts, the ability to suppress the growth of human pathogens, the capacity to assimilate wide range of carbohydrates and to produce potentially beneficial enzymes. Both spores and vegetative cells of this strain were able to adhere to a mucous-producing intestinal cell line and to attenuate the LPS- and Poly I:C-triggered pro-inflammatory cytokine gene expression in HT-29 intestinal cell line. Vegetative cells of B. clausii CSI08 were also able to elicit a robust immune response in U937-derived macrophages. Furthermore, B. clausii CSI08 demonstrated cytoprotective effects in in vitro cell culture and in vivo C. elegans models of oxidative stress. Taken together, these beneficial properties provide strong evidence for B. clausii CSI08 as a promising potential probiotic.
Collapse
Affiliation(s)
- Ekaterina Khokhlova
- Deerland Ireland R&D, Ltd., ADM, Bio-Innovation Unit, Rm. 331 Food Science Building, College Rd., University College Cork, T12 K8AF Cork, Ireland
| | - Joan Colom
- Deerland Ireland R&D, Ltd., ADM, Bio-Innovation Unit, Rm. 331 Food Science Building, College Rd., University College Cork, T12 K8AF Cork, Ireland
| | - Annie Simon
- Deerland Ireland R&D, Ltd., ADM, Bio-Innovation Unit, Rm. 331 Food Science Building, College Rd., University College Cork, T12 K8AF Cork, Ireland
| | - Shahneela Mazhar
- Deerland Ireland R&D, Ltd., ADM, Bio-Innovation Unit, Rm. 331 Food Science Building, College Rd., University College Cork, T12 K8AF Cork, Ireland
| | - Guillermo García-Lainez
- Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis S.L. Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980 Paterna, Spain
| | - Silvia Llopis
- Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis S.L. Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980 Paterna, Spain
| | - Nuria Gonzalez
- Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis S.L. Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980 Paterna, Spain
| | - María Enrique-López
- Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis S.L. Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980 Paterna, Spain
| | - Beatriz Álvarez
- Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis S.L. Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980 Paterna, Spain
| | - Patricia Martorell
- Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis S.L. Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980 Paterna, Spain
| | - Marta Tortajada
- Archer Daniels Midland, Nutrition, Health&Wellness, Biopolis S.L. Parc Científic Universitat de València, C/ Catedrático Agustín Escardino Benlloch, 9, 46980 Paterna, Spain
| | - John Deaton
- Deerland Probiotics & Enzymes, ADM, Science and Technology Department, 3800 Cobb International Blvd., Kennesaw, GA 30152, USA
| | - Kieran Rea
- Deerland Ireland R&D, Ltd., ADM, Bio-Innovation Unit, Rm. 331 Food Science Building, College Rd., University College Cork, T12 K8AF Cork, Ireland
- Correspondence:
| |
Collapse
|
6
|
Mazhar S, Khokhlova E, Colom J, Simon A, Deaton J, Rea K. In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111 ®. Front Microbiol 2023; 13:1101144. [PMID: 36713219 PMCID: PMC9880548 DOI: 10.3389/fmicb.2022.1101144] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2022] [Accepted: 12/21/2022] [Indexed: 01/14/2023] Open
Abstract
Bacillus subtilis DE111® is a safe, well-tolerated commercially available spore-forming probiotic that has been clinically shown to support a healthy gut microbiome, and to promote digestive and immune health in both adults and children. Recently it was shown that this spore-forming probiotic was capable of germinating in the gastrointestinal tract as early as 3 h after ingestion. However, a better understanding of the mechanisms involved in the efficacy of DE111® is required. Therefore, the present investigation was undertaken to elucidate the functional properties of DE111® through employing a combination of in vitro functional assays and genome analysis. DE111® genome mining revealed the presence of several genes encoding acid and stress tolerance mechanisms in addition to adhesion proteins required to survive and colonize harsh gastrointestinal environment including multi subunit ATPases, arginine deiminase (ADI) pathway genes (argBDR), stress (GroES/GroEL and DnaK/DnaJ) and extracellular polymeric substances (EPS) biosynthesis genes (pgsBCA). DE111® harbors several genes encoding enzymes involved in the metabolism of dietary molecules (protease, lipases, and carbohyrolases), antioxidant activity and genes associated with the synthesis of several B-vitamins (thiamine, riboflavin, pyridoxin, biotin, and folate), vitamin K2 (menaquinone) and seven amino acids including five essential amino acids (threonine, tryptophan, methionine, leucine, and lysine). Furthermore, a combined in silico analysis of bacteriocin producing genes with in vitro analysis highlighted a broad antagonistic activity of DE111® toward numerous urinary tract, intestinal, and skin pathogens. Enzymatic activities included proteases, peptidases, esterase's, and carbohydrate metabolism coupled with metabolomic analysis of DE111® fermented ultra-high temperature milk, revealed a high release of amino acids and beneficial short chain fatty acids (SCFAs). Together, this study demonstrates the genetic and phenotypic ability of DE111® for surviving harsh gastric transit and conferring health benefits to the host, in particular its efficacy in the metabolism of dietary molecules, and its potential to generate beneficial SCFAs, casein-derived bioactive peptides, as well as its high antioxidant and antimicrobial potential. Thus, supporting the use of DE111® as a nutrient supplement and its pottential use in the preparation of functional foods.
Collapse
Affiliation(s)
- Shahneela Mazhar
- Deerland Ireland R&D Ltd., ADM, Food Science Building, University College Cork, Cork, Ireland
| | - Ekaterina Khokhlova
- Deerland Ireland R&D Ltd., ADM, Food Science Building, University College Cork, Cork, Ireland
| | - Joan Colom
- Deerland Ireland R&D Ltd., ADM, Food Science Building, University College Cork, Cork, Ireland
| | - Annie Simon
- Deerland Ireland R&D Ltd., ADM, Food Science Building, University College Cork, Cork, Ireland
| | - John Deaton
- Deerland Probiotics and Enzymes, ADM, Kennesaw, GA, United States
| | - Kieran Rea
- Deerland Ireland R&D Ltd., ADM, Food Science Building, University College Cork, Cork, Ireland,*Correspondence: Kieran Rea, ✉
| |
Collapse
|
7
|
Simon A, Colom J, Mazhar S, Khokhlova E, Deaton J, Rea K. Bacillus megaterium Renuspore ® as a potential probiotic for gut health and detoxification of unwanted dietary contaminants. Front Microbiol 2023; 14:1125616. [PMID: 37113219 PMCID: PMC10126418 DOI: 10.3389/fmicb.2023.1125616] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2022] [Accepted: 03/13/2023] [Indexed: 04/29/2023] Open
Abstract
Exposure to diverse environmental pollutants and food contaminants is ever-increasing. The risks related to the bioaccumulation of such xenobiotics in the air and food chain have exerted negative effects on human health, such as inflammation, oxidative stress, DNA damage, gastrointestinal disorders, and chronic diseases. The use of probiotics is considered an economical and versatile tool for the detoxification of hazardous chemicals that are persistent in the environment and food chain, potentially for scavenging unwanted xenobiotics in the gut. In this study, Bacillus megaterium MIT411 (Renuspore®) was characterized for general probiotic properties including antimicrobial activity, dietary metabolism, and antioxidant activity, and for the capacity to detoxify several environmental contaminants that can be found in the food chain. In silico studies revealed genes associated with carbohydrate, protein and lipid metabolism, xenobiotic chelation or degradation, and antioxidant properties. Bacillus megaterium MIT411 (Renuspore®) demonstrated high levels of total antioxidant activities, in addition to antimicrobial activity against Escherichia coli, Salmonella enterica, Staphylococcus aureus, and Campylobacter jejuni in vitro. The metabolic analysis demonstrated strong enzymatic activity with a high release of amino acids and beneficial short-chain fatty acids (SCFAs). Moreover, Renuspore® effectively chelated the heavy metals, mercury and lead, without negatively impacting the beneficial minerals, iron, magnesium, or calcium, and degraded the environmental contaminants, nitrite, ammonia, and 4-Chloro-2-nitrophenol. These findings suggest that Renuspore® may play a beneficial role in supporting gut health metabolism and eliminating unwanted dietary contaminants.
Collapse
Affiliation(s)
- Annie Simon
- ADM Cork H&W Ltd., Bioinnovation Unit, University College Cork, Cork, Ireland
| | - Joan Colom
- ADM Cork H&W Ltd., Bioinnovation Unit, University College Cork, Cork, Ireland
| | - Shahneela Mazhar
- ADM Cork H&W Ltd., Bioinnovation Unit, University College Cork, Cork, Ireland
| | - Ekaterina Khokhlova
- ADM Cork H&W Ltd., Bioinnovation Unit, University College Cork, Cork, Ireland
| | - John Deaton
- Deerland Probiotics and Enzymes/ADM, Kennesaw, GA, United States
| | - Kieran Rea
- ADM Cork H&W Ltd., Bioinnovation Unit, University College Cork, Cork, Ireland
- *Correspondence: Kieran Rea
| |
Collapse
|